On May 28, 2021, China Renaissance held its inaugural "AI-Powered New Drug Discovery Summit" in Beijing, which focused on exploring the application of AI in the research and development phase of new drugs through the use of innovative AI algorithms and AI engineering, as well as discussing outcomes and challenges involved in the application of AI in the field. The summit brought together approximately 20 top Chinese biomedicine entrepreneurs and 50 leading investors to discuss the future of AI-enhanced drug discovery through thought-provoking conversations and exchange of ideas. 

Since its inception in 2008, China Renaissance's Healthcare and Life Sciences Financial Advisory Team has provided financial advisory services for more than 150 financing and M&A projects. Over the past 13 years, we have been committed to supporting the growth of start-ups in the healthcare and life sciences sector, including organizing a series of summits and events attended by industry leaders and investors to build a community of experts dedicated to advancing the development of the healthcare and life sciences sector through open discussions.    

-End-